About Us:
Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). The Company’s antibody therapy, ersodetug, is designed to treat all forms of HI and has shown substantial benefit in clinical trials and real-world use for the treatment of congenital HI and tumor HI.
Address:
275 Shoreline Dr, Suite 500
Redwood City, CA 94065
United States
Phone:
(650) 206-4507
Email:
davelyn@rezolutebio.com
Website:
Brief summary of video content:
In development.
Have questions? Please contact:
Enter the MAP Spotlight Raffle